Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SOPHiA GENETICS SA SOPH

Technology Software - Application
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.


NDAQ:SOPH - Post by User

SOPHiA GENETICS SA
<< Previous
 Bullboard Posts
User Avatar Image
(291)
•••
Post by whytestockson Nov 05, 2024 10:02pm
30 Views
Post# 36298021

SOPHiA GENETICS Reports Third Quarter 2024 Results

SOPHiA GENETICS Reports Third Quarter 2024 Results
NEWS: $SOPH SOPHiA GENETICS Reports Third Quarter 2024 ResultsSOPHiA GENETICS Reports Third Quarter 2024 Results PR Newswire Clinical growth reaccelerates with record analysis volume; Cash burn improves 39% BOSTON and ROLLE, Switzerland , Nov. 5, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-nativ...SOPH - SOPHiA GENETICS Reports Third Quarter 2024 Results

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities